TORTORA, GIAMPAOLO
TORTORA, GIAMPAOLO
Phase I clinical study with 8-Chloro-cAMP and evaluation of immunological effects in cancer patients.
1995 Tortora, Giampaolo; Ciardiello, F.; Pepe, Stefano; Tagliaferri, P.; Ruggiero, A.; Bianco, C.; Guarrasi, R.; Miki, K.; Bianco, A. R.
Down-regulation of type I protein kinase A by transfection of human breast cancer cells with an epidermal growth factor receptor antisense expression vector.
1998 Ciardiello, F; Dixit, M; di Isernia, G; Damiano, Vincenzo; Bianco, Roberto; Bianco, Ar; Arteaga, Cl; Tortora, Giampaolo
Effects of mutant p53 genes on transformation of human mammary epithelial cells.
1994 Bianco, C.; Tortora, Giampaolo; Basolo, F.; Fiore, L.; Fontanini, G.; Merlo, G.; Salomon, D. S.; Bianco, A. R.; Ciardiello, F.
Inhibition of Cripto expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides.
1994 Ciardiello, F.; Tortora, Giampaolo; Bianco, C.; Selvam, M. P.; Basolo, F.; Fontanini, G.; Pacifico, F.; Normanno, N.; Brandt, R.; Persico, M. G.; Salomon, D. S.; Bianco, A. R.
Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer.
2007 Tabernero, J; Van Cutsem, E; Díaz Rubio, E; Cervantes, A; Humblet, Y; André, T; Van Laethem, Jl; Soulié, P; Casado, E; Verslype, C; Sastre Valera, J; Tortora, Giampaolo; Ciardiello, F; Kisker, O; de Gramont, A.
Rational combination of targeted therapies as a strategy to overcome the mechanisms of resistance to inhibitors of EGFR signaling.
2007 Bianco, Roberto; Damiano, V; Gelardi, T; Daniele, G; Ciardiello, F; Tortora, Giampaolo
8-Chloro-cAMP enhances the growth inhibitory effect of cytotoxic drugs in human colon cancer cells
1996 di Isernia, G.; Ciardiello, F.; Sandomenico, C.; Pepe, Stefano; Bianco, A. R.; Tortora, Giampaolo
ZD1839 (Iressa): preclinical studies and pharmacology.
2002 Ciardiello, Fortunato; Tortora, Giampaolo; DE PLACIDO, Sabino; Bianco, ANGELO RAFFAELE
Strategies for multiple signalling inhibition.
2004 Tortora, Giampaolo; Bianco, Roberto; Daniele, Gennaro
Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors.
1995 Tortora, Giampaolo; F., Ciardiello; Damiano, Vincenzo; Pepe, Stefano; C., Bianco; G., di Isernia; S. L., Davies; P., North; A. L., Harris; I. D., Hickson; Bianco, ANGELO RAFFAELE
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors.
2005 M. P., Morelli; T., Cascone; Troiani, Teresa; F., De Vita; M., Orditura; Laus, Gianluca; S. G., Eckhardt; Pepe, Stefano; Tortora, Giampaolo; F. C. i. a. r. d. i. e. l. l., O.
Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs.
2003 Ciardiello, F; Tortora, Giampaolo
8-Chloro-cyclic AMP inhibits autocrine and angiogenic growth factor production in human colorectal and breast cancer.
1997 Bianco, C; Tortora, Giampaolo; Baldassarre, G; Caputo, R; Fontanini, G; Chine, S; Bianco, Ar; Ciardiello, F.
Anti-epidermal growth factor receptor drugs in cancer therapy.
2002 Ciardiello, F; Tortora, Giampaolo
Inhibition of growth factors production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
2001 Ciardiello, F; Caputo, R; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo
Helicobacter pylori VacA toxin up-regulates Vascular endothelial growth factor expression in MKN 28 gastric cells through an Epidermal growth factor receptor-, Cyclooxygenase-2-dependent mechanism
2003 Caputo, R; Tuccillo, C; Manzo, Ba; Zarrilli, R; Tortora, Giampaolo; DEL VECCHIO BLANCO, C; Ricci, V; Ciardiello, F; Romano, M.
Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor Iressa causes cooperative antitumor and antiangiogenic activity.
2001 Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Fontanini, G; Melisi, Davide; Veneziani, BIANCA MARIA; Zunino, F; Bianco, Ar; Ciardiello, F.
Preclinical and phase I study of oxaliplatin and topotecan in combination in human cancer.
2002 Tortora, Giampaolo; Ciardiello, F; Damiano, V; DE LAURENTIIS, Michelino; Matano, E; Pepe, S; Pensabene, M; Catalano, G; DE PLACIDO, Sabino; Bianco, A. R.
EGFR antagonists in cancer treatment.
2008 Ciardiello, F.; Tortora, Giampaolo
Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells.
2008 Cascone, T; Morelli, Mp; Morgillo, F; Kim, Wy; Rodolico, G; Pepe, Stefano; Tortora, Giampaolo; Berrino, L; Lee, Hy; Heymach, Jv; Ciardiello, F.
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Phase I clinical study with 8-Chloro-cAMP and evaluation of immunological effects in cancer patients. | 1.1 Articolo in rivista | 1995 | Tortora, Giampaolo; Ciardiello, F.; Pepe, Stefano; Tagliaferri, P.; Ruggiero, A.; Bianco, C.; Guarrasi, R.; Miki, K.; Bianco, A. R. | |
| Down-regulation of type I protein kinase A by transfection of human breast cancer cells with an epidermal growth factor receptor antisense expression vector. | 1.1 Articolo in rivista | 1998 | Ciardiello, F; Dixit, M; di Isernia, G; Damiano, Vincenzo; Bianco, Roberto; Bianco, Ar; Arteaga, Cl; Tortora, Giampaolo | |
| Effects of mutant p53 genes on transformation of human mammary epithelial cells. | 1.1 Articolo in rivista | 1994 | Bianco, C.; Tortora, Giampaolo; Basolo, F.; Fiore, L.; Fontanini, G.; Merlo, G.; Salomon, D. S.; Bianco, A. R.; Ciardiello, F. | |
| Inhibition of Cripto expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides. | 1.1 Articolo in rivista | 1994 | Ciardiello, F.; Tortora, Giampaolo; Bianco, C.; Selvam, M. P.; Basolo, F.; Fontanini, G.; Pacifico, F.; Normanno, N.; Brandt, R.; Persico, M. G.; Salomon, D. S.; Bianco, A. R. | |
| Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer. | 1.1 Articolo in rivista | 2007 | Tabernero, J; Van Cutsem, E; Díaz Rubio, E; Cervantes, A; Humblet, Y; André, T; Van Laethem, Jl; Soulié, P; Casado, E; Verslype, C; Sastre Valera, J; Tortora, Giampaolo; Ciardiello, F; Kisker, O; de Gramont, A. | |
| Rational combination of targeted therapies as a strategy to overcome the mechanisms of resistance to inhibitors of EGFR signaling. | 1.1 Articolo in rivista | 2007 | Bianco, Roberto; Damiano, V; Gelardi, T; Daniele, G; Ciardiello, F; Tortora, Giampaolo | |
| 8-Chloro-cAMP enhances the growth inhibitory effect of cytotoxic drugs in human colon cancer cells | 1.1 Articolo in rivista | 1996 | di Isernia, G.; Ciardiello, F.; Sandomenico, C.; Pepe, Stefano; Bianco, A. R.; Tortora, Giampaolo | |
| ZD1839 (Iressa): preclinical studies and pharmacology. | 1.1 Articolo in rivista | 2002 | Ciardiello, Fortunato; Tortora, Giampaolo; DE PLACIDO, Sabino; Bianco, ANGELO RAFFAELE | |
| Strategies for multiple signalling inhibition. | 1.1 Articolo in rivista | 2004 | Tortora, Giampaolo; Bianco, Roberto; Daniele, Gennaro | |
| Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors. | 1.1 Articolo in rivista | 1995 | Tortora, Giampaolo; F., Ciardiello; Damiano, Vincenzo; Pepe, Stefano; C., Bianco; G., di Isernia; S. L., Davies; P., North; A. L., Harris; I. D., Hickson; Bianco, ANGELO RAFFAELE | |
| Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors. | 1.1 Articolo in rivista | 2005 | M. P., Morelli; T., Cascone; Troiani, Teresa; F., De Vita; M., Orditura; Laus, Gianluca; S. G., Eckhardt; Pepe, Stefano; Tortora, Giampaolo; F. C. i. a. r. d. i. e. l. l., O. | |
| Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs. | 1.1 Articolo in rivista | 2003 | Ciardiello, F; Tortora, Giampaolo | |
| 8-Chloro-cyclic AMP inhibits autocrine and angiogenic growth factor production in human colorectal and breast cancer. | 1.1 Articolo in rivista | 1997 | Bianco, C; Tortora, Giampaolo; Baldassarre, G; Caputo, R; Fontanini, G; Chine, S; Bianco, Ar; Ciardiello, F. | |
| Anti-epidermal growth factor receptor drugs in cancer therapy. | 1.1 Articolo in rivista | 2002 | Ciardiello, F; Tortora, Giampaolo | |
| Inhibition of growth factors production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. | 1.1 Articolo in rivista | 2001 | Ciardiello, F; Caputo, R; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo | |
| Helicobacter pylori VacA toxin up-regulates Vascular endothelial growth factor expression in MKN 28 gastric cells through an Epidermal growth factor receptor-, Cyclooxygenase-2-dependent mechanism | 1.1 Articolo in rivista | 2003 | Caputo, R; Tuccillo, C; Manzo, Ba; Zarrilli, R; Tortora, Giampaolo; DEL VECCHIO BLANCO, C; Ricci, V; Ciardiello, F; Romano, M. | |
| Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor Iressa causes cooperative antitumor and antiangiogenic activity. | 1.1 Articolo in rivista | 2001 | Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Fontanini, G; Melisi, Davide; Veneziani, BIANCA MARIA; Zunino, F; Bianco, Ar; Ciardiello, F. | |
| Preclinical and phase I study of oxaliplatin and topotecan in combination in human cancer. | 1.1 Articolo in rivista | 2002 | Tortora, Giampaolo; Ciardiello, F; Damiano, V; DE LAURENTIIS, Michelino; Matano, E; Pepe, S; Pensabene, M; Catalano, G; DE PLACIDO, Sabino; Bianco, A. R. | |
| EGFR antagonists in cancer treatment. | 1.1 Articolo in rivista | 2008 | Ciardiello, F.; Tortora, Giampaolo | |
| Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells. | 1.1 Articolo in rivista | 2008 | Cascone, T; Morelli, Mp; Morgillo, F; Kim, Wy; Rodolico, G; Pepe, Stefano; Tortora, Giampaolo; Berrino, L; Lee, Hy; Heymach, Jv; Ciardiello, F. |